Recent general releases

Mootral receives funding from the Swiss Climate Foundation to reduce methane emissions from cows

[PRESSWIRE] Rolle, Switzerland – 16 May 2019 --  Mootral is proud to announce that the Swiss Climate Foundation has endorsed and decided to help fund its efforts to protect the climate by reducing cattle’s methane emissions.

FREE DENTAL CONSULTATION PACKAGE IN BUDAPEST, THE FIRST STEP TO SAVING UP TO 70% ON COSTS

[PRESSWIRE] Hungary – 09 May, 2019 -- People go from all parts of the world to Budapest (Hungary, Europe) to get their teeth fixed and save up to 70% on dental care. It is no matter if it is about a complete smile makeover or just some lost teeth should be replaced by implants or a couple of crowns should be fitted, one of the most preferred destinations is Budapest.

Why A Brooklyn Startup Wants To Slash Your Furniture In Half

[PRESSWIRE] New York - 07 May, 2019 -- Today, a direct to consumer Brooklyn-based company called Slash launches affordable, premium furniture that delivers to your doorstep and assembles in minutes.

EUROPE’S PUBLISHERS SUPPORT WORLD PRESS FREEDOM DAY: WE UNDERMINE OUR PROFESSIONAL PRESS AT OUR PERIL

[PRESSWIRE] Brussels – 03 May – 2019 -- The European Publishers Council (EPC) is delighted to sponsor the fifth edition of “Difference Day” taking place in Brussels today, 3 May, to celebrate UN World Press Freedom Day.

Average New-Car Prices Up 2 Percent Year-Over-Year for April 2019, According to Kelley Blue Book

 [PRESSWIRE] IRVINE, Calif. - May 1, 2019 -- The valuation analysts at Kelley Blue Book today reported the estimated average transaction price for a light vehicle in the United States was $36,843 in April 2019. New-vehicle prices increased $732 (up 2 percent) from April 2018, while rising $93 (up 0.3 percent) from last month.   

Mendix University Program Celebrates 100 Universities Bringing Mendix into the Classroom

 [PRESSWIRE] BOSTON - May 1, 2019 -- Mendix, a Siemens business and the global leader in low-code for the enterprise, today announced that more than 100 universities across the U.S., UK, Netherlands, and nine other countries have incorporated the Mendix University Program into their curricula.

Camp MASTERCHEF 2019 Announces Additional All-Star Talent Including Finalists From MASTERCHEF JUNIOR Season 7

[PRESSWIRE] LOS ANGELES - May 1, 2019 -- Endemol Shine North America, the producers behind MASTERCHEF and MASTERCHEF JUNIOR, announced today the lineup of fan-favorite contestants, including the top 10 finalists from the current season of MASTERCHEF JUNIOR, airing Tuesdays (8:00-9:00 PM ET/PT) on FOX, who will make special appearances at CAMP MASTERCHEF, the culinary camps for kids and teens ages 8-16.

The Loro Parque’s World Population Clock breaks the 7,700 million barrier

[PRESSWIRE] Tenerife, the Canary Islands - 29 April, 2019 -- Loro Parque’s World Population Clock, based on estimates by the United Nations’ Department of Economic and Social Affairs, has this week reached the historic figure of 7,700 million people.  According to this population growth trend, by 2023 there will be more than 8,000 million people and 10,000 million by 2056.  Meaning that there are more and more inhabitants, but also more endangered species.

Novel therapies slow CKD progression in patients with diabetes

[PRESSWIRE] Parma - April 26, 2019 -- The recently published CREDENCE study [1] showed that SGLT2 inhibitors can slow progression of chronic kidney disease (CKD) in diabetes patients in addition to the effects seen with RAAS blockade. The study results were presented at the World Nephrology Congress in Melbourne and showed that Canagliflozin was associated with a 34% risk reduction of the renal end point (end stage renal disease, doubling of serum creatinine or renal death). The previous day, the SONAR study had shown that the selective endothelin A receptor antagonist, atrasentan, reduced the risk of renal events in a specially selected CKD cohort with diabetes to a similar extent (35%).

BioPharmX Announces $3.9 Million Offering

 [PRESSWIRE] SAN JOSE, Calif., March 21, 2019 -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 43,645,000 shares of common stock at a price of $0.09 per share in a registered direct offering. The gross proceeds of the offering are expected to be approximately $3.9 million.